Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could difficulty naming emotions worsen chronic tailbone pain?

NCT ID NCT07696260

Recruiting now Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study investigates whether people with chronic tailbone pain (lasting 3 months or more) also have alexithymia — a condition where it's hard to identify and describe emotions. Researchers will use questionnaires to measure alexithymia, pain intensity, mood, childhood trauma, and quality of life in 15 participants. The goal is to understand how emotional awareness might relate to pain severity and overall well-being, which could lead to more comprehensive treatment approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this study finds a link between alexithymia and chronic tailbone pain, it could point toward more holistic, mind-body treatments for this condition.
What could go wrong
This is a very small, early observational study with only 15 participants. It cannot prove cause and effect, and results may not apply to everyone with chronic coccydynia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALEXITHYMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Affective Symptoms alexithymia Chronic Pain coccygodynia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALEXITHYMIA CHRONIC COCCYDYNIA

Contacts and locations

Locations

  • Marmara University Pendik Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.